Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Wild Bioscience secures €51 million in Series A funding to enhance R&D and commercial operations in precision-breeding wheat, led by The Ellison Institute of Technology and others.
PRIVATEJul 29, 2026•about 23 hours ago
Amount Raised
€51 Million
Round Type
Series A
OxfordBiotechnology
Investors
University Of OxfordBraavos CapitalOxford Science EnterprisesThe Ellison Institute Of Technology
Description
Wild Bioscience has successfully raised €51 million in Series A funding to support its mission of creating Britain’s first independent precision-breeding wheat business. The funding will aid in expanding its research and development as well as its commercial operations. The investment comes from notable backers including The Ellison Institute of Technology and Oxford Science Enterprises. Wild Bio is now poised to turn its early field successes into market-ready seed varieties.
Company Information
Company
Wild Bioscience
Location
Oxford, England, United Kingdom
About
Wild Bioscience is an Oxford University spinout focused on developing improved crop varieties through AI and precision breeding. The company specializes in crop genetics and utilizes a unique data-driven approach to enhance crop productivity, climate resilience, and sustainability. Founded by Dr. Ross Hendron and Prof. Steve Kelly in 2021, Wild Bio translates scientific research into practical agricultural solutions. With a growing team of 30, they are currently expanding their R&D and commercial operations.
OxfordBiotechnology